Novel bionic eyes for the blind in the making

British scientists have developed the first pair of bionic glasses that could help thousands of legally blind people. These glasses using tiny cameras and software technology from video games, alert the wearer to objects in their surroundings using flashing lights.

12703_summersciexhibit2Video cameras attached to the rim of the glasses capture information about the distance and dimension of objects. This information is then sent via a wire to a computer processor in the wearer's pocket, which interprets the object as a pattern of dots. Small LEDs built into the lenses then light up in the shape of the pattern. Brighter lights suggest closer objects.

This came from neuroscientist, Stephen Hicks who explained that the glasses had an advantage over the bionic eye, or retinal implants, because they were cheap and non-invasive. “Essentially they are just an iPhone and a pair of glasses.” The glasses would be ideal for elderly people with macular degeneration, who see objects as a blur but cannot focus, see much color or make out specifics he said.

Over the next six months Dr Hicks, a research associate at the University of Oxford, and his team will trial the prototypes on 60 people who are legally blind. Advances in smart phone technology mean Dr Hicks's glasses can be controlled with a palm-sized computer, and will eventually use a wireless connection. Dr Hicks, who presented his invention at The Royal Society's summer science exhibition in London last week said, “A couple of years ago we would have had a laptop in a backpack.” “There is also a lot of software that can do face recognition and tracking so we are adopting techniques like that too,” he added. He envisages the glasses eventually being able to read bus numbers and signs, which can be synthesized into a voice and played into the wearer's ear.

The glasses could be ready for sale by 2014 if tests are successful. The FDA also last year approved a miniature implantable eye telescope that can help people with age-related macular degeneration to better see fine detail.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2022, December 22). Novel bionic eyes for the blind in the making. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20110714/Novel-bionic-eyes-for-the-blind-in-the-making.aspx.

  • MLA

    Mandal, Ananya. "Novel bionic eyes for the blind in the making". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20110714/Novel-bionic-eyes-for-the-blind-in-the-making.aspx>.

  • Chicago

    Mandal, Ananya. "Novel bionic eyes for the blind in the making". News-Medical. https://www.news-medical.net/news/20110714/Novel-bionic-eyes-for-the-blind-in-the-making.aspx. (accessed November 24, 2024).

  • Harvard

    Mandal, Ananya. 2022. Novel bionic eyes for the blind in the making. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20110714/Novel-bionic-eyes-for-the-blind-in-the-making.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Long-term low-dose antiviral treatment reduces eye disease risk from shingles